- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05511597
Split-belt Treadmill Training for Freezing of Gait in Parkinson's Disease (SBT FOG-TRAIN)
February 6, 2024 updated by: Alice Nieuwboer, KU Leuven
Turning Around Freezing: Effect of Split-belt Treadmill Training on Daily-life Turning-related Freezing of Gait in Parkinson's Disease
A split-belt treadmill (SBT) is a treadmill with two belts, whereby each leg can be driven at a different speed.
Previous work by the investigators showed that one session of SBT training improved turning while multi-tasking and reduced FOG in PwPD tested in the laboratory.
However, subsequent work raises questions as to whether treadmill improvements following repeated SBT training generalize to overground situations in the long term.
Therefore, in this study, the investigators will perform a four-week SBT intervention with added practice of everyday turning scenarios (SBT+CP) or placebo exercise (SBT+PL), and study its effects on FOG in both the laboratory and at home.
Study Overview
Status
Enrolling by invitation
Study Type
Interventional
Enrollment (Estimated)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Leuven, Belgium, 3001
- Faculty of Movement and Rehabilitation Sciences (FaBeR)
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
38 years to 88 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
- Be between 40 - 90 years of age
- Have a diagnosis of Parkinson's disease
- Be able to walk for 10 min without an aid
- Be able to follow and understand the oral instructions of the investigator
- Have a disease stage of I to IV (while ON-medication)
- Have had no change in your Parkinson's medication in the past month (or to your deep brain stimulator if applicable) and also no planned changes in medication over the next 4 months
- Have at least about 1 "freezing" episode per day (based on the New Freezing of Gait Questionnaire: N-FOG)
- Not participating in another clinical trial
- Have no acute joint disease
- Not have any other condition that affects your walking pattern or prevents you from completing all study tasks
- Have not undergone major surgery or hospitalization in the last 3 months
- No substance abuse
- No depressive disorder or other apathetic disorder that precludes daily exercise
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: SBT+CP
Split-belt training + complex task practice
|
Split-belt walking with various speed ratios between the two legs, applied with random-block practice
Overground gait flexibility training with added cognitive tasks
|
Active Comparator: SBT+PL
Split-belt training + static exercise
|
Split-belt walking with various speed ratios between the two legs, applied with random-block practice
Mindfulness and breathing combined with static balance exercises
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percentage Time Frozen during turning in place
Time Frame: up to 8 weeks post intervention
|
Percentage Time Frozen scored from video of rapid alternating full turns in place.
Based on earlier work showing immediate effects of SBT training on FOG during this task.
|
up to 8 weeks post intervention
|
Time to complete Timed Up and Go (TUG)
Time Frame: up to 8 weeks post intervention
|
Overall time to complete the Timed Up and Go task.
The training is expected to improve multiple transitions between straight walking and turning and should be reflected in the overall task time.
|
up to 8 weeks post intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percentage Time Frozen over all FOG-provoking tasks
Time Frame: up to 8 weeks post intervention
|
Percentage Time Frozen scored from videos of Turning in place,TUG, Hotspot door and Hotspot personalized.
|
up to 8 weeks post intervention
|
Percentage Time Frozen over 1-week free-living monitoring
Time Frame: up to 8 weeks post intervention
|
Percentage Time Frozen estimated from machine learning algorithm using free-living sensor data captured over 1 week.
|
up to 8 weeks post intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Alice Nieuwboer, PhD, KU Leuven
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- D'Cruz N, Seuthe J, De Somer C, Hulzinga F, Ginis P, Schlenstedt C, Nieuwboer A. Dual Task Turning in Place: A Reliable, Valid, and Responsive Outcome Measure of Freezing of Gait. Mov Disord. 2022 Feb;37(2):269-278. doi: 10.1002/mds.28887. Epub 2021 Dec 22.
- D'Cruz N, Seuthe J, Ginis P, Hulzinga F, Schlenstedt C, Nieuwboer A. Short-Term Effects of Single-Session Split-Belt Treadmill Training on Dual-Task Performance in Parkinson's Disease and Healthy Elderly. Front Neurol. 2020 Sep 30;11:560084. doi: 10.3389/fneur.2020.560084. eCollection 2020.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 16, 2022
Primary Completion (Estimated)
December 31, 2024
Study Completion (Estimated)
December 31, 2024
Study Registration Dates
First Submitted
August 18, 2022
First Submitted That Met QC Criteria
August 19, 2022
First Posted (Actual)
August 23, 2022
Study Record Updates
Last Update Posted (Estimated)
February 7, 2024
Last Update Submitted That Met QC Criteria
February 6, 2024
Last Verified
February 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- S65984
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson Disease
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedParkinson Disease 6, Early-Onset | Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human | Parkinson Disease Autosomal Recessive, Early Onset | Parkinson Disease, Autosomal Recessive Early-Onset, Digenic, Pink1/Dj1United States
-
ProgenaBiomeRecruitingParkinson Disease | Parkinsons Disease With Dementia | Parkinson-Dementia Syndrome | Parkinson Disease 2 | Parkinson Disease 3 | Parkinson Disease 4United States
-
King's College LondonGlaxoSmithKlineCompletedParkinson Disease | Idiopathic Parkinson Disease | Parkinson Disease, PARK8United Kingdom
-
Ohio State UniversityCompletedParkinson's Disease | Parkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease | Parkinson Disease, Idiopathic | Parkinson's Disease, IdiopathicUnited States
-
National Yang Ming UniversityUnknownEarly Onset Parkinson Disease | Early Stage Parkinson Disease
-
Michele Tagliati, MDRecruitingREM Sleep Behavior Disorder | Symptomatic Parkinson Disease | Pre-motor Parkinson DiseaseUnited States
-
Cedars-Sinai Medical CenterEnrolling by invitationREM Sleep Behavior Disorder | Symptomatic Parkinson Disease | Pre-motor Parkinson DiseaseUnited States
-
Mahatma Gandhi Institute of Medical SciencesCompletedStroke, Parkinson' s Disease, Neurological Impairments, Tele-rehabilitationIndia
-
Merck Sharp & Dohme LLCCompletedParkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease
-
University of DeustoCompletedPARKINSON DISEASE (Disorder)Spain
Clinical Trials on Split-belt treadmill training
-
University of TorontoRecruitingParkinson Disease | Freezing of Gait | Gait, UnsteadyCanada
-
KU LeuvenUniversity of KielCompletedParkinson Disease | Freezing of GaitGermany, Belgium
-
Cairo UniversityCompletedCerebral PalsySaudi Arabia
-
Hugo W. Moser Research Institute at Kennedy Krieger...Eunice Kennedy Shriver National Institute of Child Health and Human Development...Completed
-
Hugo W. Moser Research Institute at Kennedy Krieger...University of Maryland; National Institutes of Health (NIH); National Institute... and other collaboratorsCompleted
-
University of FloridaWithdrawn
-
Chapman UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...Recruiting
-
Colorado State UniversityNational Multiple Sclerosis SocietyRecruitingMultiple SclerosisUnited States
-
Hugo W. Moser Research Institute at Kennedy Krieger...Eunice Kennedy Shriver National Institute of Child Health and Human Development...Completed